Paper3691593
Nisoldipine in primary Raynaud's phenomenon.
Challenor VF and 5 others. Eur J Clin Pharmacol, 1987. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Nisoldipine in primary Raynaud's phenomenon. Papers, record 3691593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3691593
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Channel Blockers | Major topic |
| Nifedipine | Major topic |
| Raynaud Disease | Major topic |
| Vasodilator Agents | Major topic |
| Adult | |
| Aged | |
| Drug Evaluation | |
| Drug Tolerance | |
| Erythrocyte Deformability | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Nisoldipine | |
| Platelet Aggregation |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3089429 | Managing Raynaud's phenomenon. | Br Med J (Clin Res Ed) | 1986 | https://conductscience.org/library/papers/3089429 | PubMed |
| 2 | 7194077 | Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). | Arzneimittelforschung | 1980 | https://conductscience.org/library/papers/7194077 | PubMed |
| 3 | 371334 | Ca-blockers and peripheral circulation--physiological viewpoints. | Acta Pharmacol Toxicol (Copenh) | 1978 | https://conductscience.org/library/papers/371334 | PubMed |
| 4 | 977787 | A simple method for measuring erythrocyte deformability. | J Clin Pathol | 1976 | https://conductscience.org/library/papers/977787 | PubMed |
| 5 | 2931096 | Ex vivo effects of nifedipine, nisoldipine and nitrendipine on filterability of red blood cells from healthy volunteers. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/2931096 | PubMed |
| 6 | 6540787 | Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome. | J Clin Pathol | 1984 | https://conductscience.org/library/papers/6540787 | PubMed |
| 7 | 6266305 | Calcium channel blockers and Raynaud's disease. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/6266305 | PubMed |
| 8 | 3533127 | Clinical and rheological effects of nifedipine in Raynaud's phenomenon. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3533127 | PubMed |
| 9 | 3723496 | Nifedipine in the treatment of idiopathic Raynaud's syndrome. | J Rheumatol | 1986 | https://conductscience.org/library/papers/3723496 | PubMed |
| 10 | 3903157 | A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon. | J Rheumatol | 1985 | https://conductscience.org/library/papers/3903157 | PubMed |
| 11 | 552299 | The two-period cross-over clinical trial. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/552299 | PubMed |
| 12 | 3756069 | Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3756069 | PubMed |
| 13 | 2994701 | Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/2994701 | PubMed |
| 14 | 4947830 | The viscosity of human blood plasma; its measurement in health and disease. | Biorheology | 1971 | https://conductscience.org/library/papers/4947830 | PubMed |
| 15 | 3590105 | Improved assessment of impedance aggregometry using a microcomputer. | Thromb Res | 1987 | https://conductscience.org/library/papers/3590105 | PubMed |
| 16 | 3816916 | Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3816916 | PubMed |
| 17 | 7392654 | The electronic aggregometer: a novel device for assessing platelet behavior in blood. | J Pharmacol Methods | 1980 | https://conductscience.org/library/papers/7392654 | PubMed |
| 18 | 3901271 | The role of platelet calcium. | Semin Hematol | 1985 | https://conductscience.org/library/papers/3901271 | PubMed |
| 19 | 4388591 | Metabolic dependence of red cell deformability. | J Clin Invest | 1969 | https://conductscience.org/library/papers/4388591 | PubMed |
| 20 | 7037872 | The treatment of severe Raynaud's phenomenon with verapamil. | J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7037872 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29237099 | Calcium channel blockers for primary and secondary Raynaud's phenomenon. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/29237099 | PubMed |
| 26914257 | Calcium channel blockers for primary Raynaud's phenomenon. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/26914257 | PubMed |
| 10503811 | Raynaud's phenomenon in older adults: diagnostic considerations and management. | Drugs Aging | 1999 | https://conductscience.org/library/papers/10503811 | PubMed |
| 3203045 | The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3203045 | PubMed |
| 3065058 | Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. | Drugs | 1988 | https://conductscience.org/library/papers/3065058 | PubMed |
| 2663416 | Management of Raynaud's phenomenon. Focus on newer treatments. | Drugs | 1989 | https://conductscience.org/library/papers/2663416 | PubMed |
| 2285650 | Pathogenesis and treatment of Raynaud's phenomenon. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2285650 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3691593
GET https://conductscience.org/api/papers/v1/3691593/references?page=2